Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with Immunotherapy

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of lung cancer. However, their clinical benefit is limited to a minority of patients. To unravel immune-related factors that are predictive of sensitivity or resistance to immunotherapy, we performed a gene expression analysis by...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Genes (Basel)
Auteurs principaux: Baglivo, Sara, Bianconi, Fortunato, Metro, Giulio, Gili, Alessio, Tofanetti, Francesca Romana, Bellezza, Guido, Ricciuti, Biagio, Mandarano, Martina, Teti, Valeria, Siggillino, Annamaria, Reda, Maria Sole, Chiari, Rita, Pistola, Lorenza, Sidoni, Angelo, Minotti, Vincenzo, Roila, Fausto, Ludovini, Vienna
Format: Artigo
Langue:Inglês
Publié: MDPI 2021
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8303258/
https://ncbi.nlm.nih.gov/pubmed/34209514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/genes12070992
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires